Your email has been successfully added to our mailing list.

×
0 0 0 0 -0.0212962962962963 -0.0208333333333333 -0.0185185185185186 -0.0486111111111111
Stock impact report

Axsome Therapeutics Provides Update on Continued Progress at Annual Stockholders’ Meeting

Axsome Therapeutics, Inc. (AXSM) 
Last axsome therapeutics, inc. earnings: 3/12 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: axsome.com
Company Research Source: GlobeNewswire
Placebo-controlled Phase 3 trial of AXS-05 in MDD on track to start in 2Q 2019 Topline results from both STRIDE-1 Phase 3 trial in TRD and planned placebo-controlled Phase 3 trial in MDD for AXS-05 still anticipated in 2H 2019 Phase 3 MOMENTUM trial of AXS-07 in migraine on track for readout of topline results in 2H 2019 Phase 2 CONCERT trial results of AXS-12 in narcolepsy now anticipated in 2H 2019 Current cash sufficient to fund anticipated operations beyond all clinical trial readouts NEW YORK, June 07, 2019 (GLOBE NEWSWIRE) --  Axsome Therapeutics, Inc. (NASDAQ: AXSM), a clinical-stage biopharmaceutical company developing novel therapies for the management of central nervous system (CNS) disorders, is providing the following update on the Company’s continued progress at its Annual Meeting of Stockholders being held today: AXS-05 AXS-05 (dextromethorphan/bupropion) is Axsome’s novel, oral, investigational NMDA receptor antagonist with multimodal activity being developed f Show less Read more
Impact Snapshot
Event Time:
AXSM
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for
AXSM alerts

from News Quantified
Opt-in for
AXSM alerts

from News Quantified